Alnylam Pharmaceuticals, Inc. (ALNY): Price and Financial Metrics
Alnylam Pharmaceuticals, Inc. (ALNY)
Today's Latest Price: $124.88 USD
1.94 (-1.53%)
Updated Oct 28 8:02pm
Add ALNY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ALNY Stock Summary
- With a one year PEG ratio of 398.71, Alnylam Pharmaceuticals Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 91.31% of US stocks.
- ALNY's price/sales ratio is 43.23; that's higher than the P/S ratio of 95.3% of US stocks.
- Revenue growth over the past 12 months for Alnylam Pharmaceuticals Inc comes in at 241.39%, a number that bests 97.24% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Alnylam Pharmaceuticals Inc, a group of peers worth examining would be GNTX, MXIM, FGEN, BMRN, and AMPH.
- ALNY's SEC filings can be seen here. And to visit Alnylam Pharmaceuticals Inc's official web site, go to www.alnylam.com.
ALNY Stock Price Chart Interactive Chart >
ALNY Price/Volume Stats
| Current price | $124.88 | 52-week high | $167.33 |
| Prev. close | $126.82 | 52-week low | $83.06 |
| Day low | $123.24 | Volume | 447,400 |
| Day high | $126.85 | Avg. volume | 696,705 |
| 50-day MA | $135.15 | Dividend yield | N/A |
| 200-day MA | $132.46 | Market Cap | 14.48B |
Alnylam Pharmaceuticals, Inc. (ALNY) Company Bio
Alnylam Pharmaceuticals is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company was founded in 2002 and is based in Cambridge, Massachusetts.
Loading social stream, please wait...